BIM-23055

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameBIM-23055
Drug Alias NameBIM-23055
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionSomatostatin receptor antagonists
TargetsSomatostatin receptor
Therapy Area/Indications +[1]  N/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIpsen SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIpsen SA
Active IndicationsN/A
Inactive Indications +[1]  N/A

Other Information

ATC CodeN/A
Related LinksN/A